Interleukin-12
Showing 1 - 25 of >10,000
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Washington, District of Columbia
- +1 more
Mar 25, 2022
Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)
Suspended
- Triple Negative Breast Cancer
- Anthracycline-refractory TNBC
- Docetaxel
- +2 more
-
Houston, TexasHouston Methodist Cancer Center
Mar 28, 2022
NSCLC Trial in Houston (Atezolizumab and Interleukin-12 Gene Therapy)
Recruiting
- Non-small Cell Lung Cancer
- Atezolizumab and Interleukin-12 Gene Therapy
-
Houston, TexasHouston Methodist Cancer Center
Mar 9, 2022
Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)
Active, not recruiting
- Prostate Cancer
- Ad5-yCD/mutTKSR39rep-hIL12
-
Detroit, MichiganHenry Ford Health System
Feb 17, 2022
HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500
Recruiting
- HIV-1-infection
- INO-6160, 2 mg
- Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
-
New York, New York
- +2 more
Apr 13, 2023
Basal Cell Carcinoma Trial in Ljubljana (phIL12 GET)
Recruiting
- Basal Cell Carcinoma
- phIL12 GET
-
Ljubljana, Slovenia
- +1 more
Nov 8, 2022
Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)
Completed
- Metastatic Pancreatic Cancer
- Ad5-yCD/mutTKSR39rep-hIL12
-
Detroit, MichiganHenry Ford Hospital
Feb 15, 2022
HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)
Completed
- HIV Infections
- Interleukin-12
- HIV-1 C4-V3 Polyvalent Peptide Vaccine
-
Chicago, Illinois
- +2 more
Oct 28, 2021
HIV Trial in United States (Interleukin-12)
Completed
- HIV Infections
- Interleukin-12
-
Los Angeles, California
- +15 more
Oct 27, 2021
Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)
Recruiting
- Hematologic and Lymphocytic Disorder
- Hematopoietic and Lymphoid Cell Neoplasm
- Placebo Administration
- +3 more
-
Duarte, California
- +3 more
Dec 14, 2022
Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA
Active, not recruiting
- Human Papillomavirus-16 Positive
- +20 more
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2022
HIV Trial in United States (PENNVAX®-GP HIV-1 DNA vaccine, Interleukin-12 (IL-12) DNA adjuvant, Placebo)
Completed
- HIV Infections
- PENNVAX®-GP HIV-1 DNA vaccine
- +2 more
-
Decatur, Georgia
- +3 more
Oct 13, 2021
HIV Trial in San Diego, Aurora, Indianapolis (Indinavir sulfate, Lamivudine/Zidovudine, Hepatitis A Vaccine (Inactivated))
Completed
- HIV Infections
- Indinavir sulfate
- +6 more
-
San Diego, California
- +2 more
Oct 27, 2021
Acute Myeloid Leukemia Trial in Toronto (IL-12)
Recruiting
- Acute Myeloid Leukemia
- IL-12
-
Toronto, Ontario, CanadaPrincess Margaret Centre Centre
Apr 16, 2021
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)
Withdrawn
- Crohn Disease
- JNJ-64304500
- +3 more
-
Evansville, IndianaMedisphere Medical Research Center, Llc
Aug 30, 2021
HIV Trial in United States (Profectus HIV MAG pDNA vaccine, IL-12, Placebo)
Completed
- HIV Infections
- Profectus HIV MAG pDNA vaccine
- +2 more
-
Los Angeles, California
- +12 more
Oct 28, 2021
Solid Tumors Trial in France, United States (MEDI9253, Durvalumab)
Recruiting
- Solid Tumors
- MEDI9253
- Durvalumab
-
La Jolla, California
- +19 more
Jul 28, 2022
Metastatic Cancer Trial in Madison (interleukin-12 gene)
Terminated
- Metastatic Cancer
- interleukin-12 gene
-
Madison, WisconsinUniversity of Wisconsin Comprehensive Cancer Center
Dec 12, 2019
Glioblastoma, Glioma, Tumors, Neuroepithelial Trial in Hangzhou (Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12,
Recruiting
- Glioblastoma
- +7 more
- Dendritic Cell/Tumor Fusion Vaccine
- +2 more
-
Hangzhou, Zhejiang, China
- +1 more
Jun 7, 2020
Kidney Tumor, Lung Tumor, Sarcoma Trial run by the NCI (rh IL-12, rh IL-2)
Terminated
- Kidney Neoplasm
- +3 more
- rh IL-12
- rh IL-2
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Melanoma Trial in United States (Tavokinogene Telseplasmid (tavo), OncoSec Medical System (OMS))
Completed
- Melanoma
- Tavokinogene Telseplasmid (tavo)
- OncoSec Medical System (OMS)
-
San Francisco, California
- +5 more
Oct 1, 2019
Atopic Dermatitis, Immunoglobulin E Concentration, Serum Trial in Jakarta Pusat (Cimetidine, Placebos)
Unknown status
- Atopic Dermatitis
- Immunoglobulin E Concentration, Serum
- Cimetidine
- Placebos
-
Jakarta Pusat, Jakarta, IndonesiaFaculty of Medicine Universitas Indonesia
Oct 2, 2019